Canada markets closed

Jabil Inc. (JBL)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
57.45-0.12 (-0.21%)
At close: 04:00PM EDT
57.50 +0.05 (+0.09%)
After hours: 06:25PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close57.57
Open58.28
Bid56.25 x 800
Ask58.40 x 900
Day's Range55.56 - 58.40
52 Week Range52.43 - 72.11
Volume817,188
Avg. Volume1,128,422
Market Cap8.113B
Beta (5Y Monthly)1.38
PE Ratio (TTM)10.60
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.32 (0.56%)
Ex-Dividend DateMay 13, 2022
1y Target EstN/A
  • Business Wire

    Jabil Healthcare Announces the Launch of the Qfinity™ Autoinjector Platform, a Reusable Drug Delivery Device with Broad Applicability

    ST. PETERSBURG, Fla., May 18, 2022--Jabil Healthcare, a division of Jabil Inc. (NYSE: JBL), announces the launch of the Qfinity™ autoinjector platform, a simple, reusable and modular solution for subcutaneous (SC) drug self-administration, at a lower cost than market alternatives — supporting the emerging prioritization of sustainable drug delivery within the pharmaceutical industry.

  • Business Wire

    Jabil Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Material and Digital Manufacturing Expansions

    ST. PETERSBURG, Fla., May 17, 2022--Jabil Inc. (NYSE: JBL) today launched PK 5000, an eco-friendly, powder-based additive material engineered to deliver improved strength, chemical resistance and resilience in comparison to general-purpose nylon materials, such as PA 12. This patent-pending material has been formulated to support highly demanding automotive, consumer electronics, defense, medical and industrial manufacturing applications. Jabil will showcase a variety of parts produced using PK

  • Business Wire

    Jabil and ams OSRAM Enable Innovative Lateral Flow Testing Platform

    ST. PETERSBURG, Fla., April 27, 2022--Jabil (NYSE: JBL) today announced the next step in its manufacturing and supply chain collaboration with ams OSRAM, a global leader in optical solutions, with the development of a lateral flow testing platform. The COVID-19 pandemic brought the topic of testing to the forefront, validating the importance of reliable and robust lab-quality testing that can be conducted remotely and with fast turnaround times. With the role of testing only increasing in the fu